How Quickly Must Medical Device Incidents Be Reported in the US, EU, UK, Canada and Australia?
A company may reach the correct reportability decision and still fail its regulatory obligation because the report was submitted after the applicable deadline.
This distinction is one of the most important practical challenges in global incident reporting.
Determining whether medical device complaints are reportable is only the first step. Manufacturers must also understand:
- Which regulatory authority must be notified.
- Which reporting timeline applies.
- When the reporting clock begins.
- Which entity is responsible for submission.
- Whether the investigation can continue after the initial report.
There is no single global deadline for medical-device incident reporting.
Depending on the jurisdiction, event category and reporting entity, initial reporting timelines may range from 48 hours to 30 days.
A complaint may therefore trigger several parallel activities:
⦿ Complaint assessment.
⦿ Medical device investigations.
⦿ Regulatory reportability review.
⦿ Authority notification.
⦿ CAPA evaluation.
⦿ Risk-management review.
⦿ Post-market surveillance activities.
Manufacturers should avoid applying one universal timeline across all markets. The same underlying event may require different assessments depending on whether it is evaluated under FDA MDR, EU MDR vigilance requirements, UK/MHRA requirements, Health Canada regulations or TGA reporting obligations.
For support with complaints and investigations, reportability assessment and vigilance governance, see: Medical Device Complaint Handling and Vigilance Review Services.
Why reporting timelines cannot be treated as one global deadline
A common mistake among multinational manufacturers is creating a single internal rule such as:
“Reports of all incidents have to be made within 30 days.”
Although this may appear operationally simple, it can create compliance risk.
Different authorities apply different concepts:
⦿ FDA focuses on MDR-reportable events and specific reporter obligations.
⦿ EU MDR uses serious incident categories under the vigilance framework.
⦿ UK/MHRA applies Great Britain vigilance requirements separately from EU MDR.
⦿ Health Canada applies mandatory incident reporting requirements based on defined categories.
⦿ TGA applies sponsor reporting requirements with different initial timelines.
Therefore, the global complaint management procedure needs to specify:
⦿ The applicable market.
⦿ The responsible reporting entity.
⦿ The event classification.
⦿ The reporting deadline.
⦿ The owner responsible for submission.
⦿ The process for follow-up information.
The reporting clock should not depend on one person recognizing the urgency. It should be built into the quality system.
When does the medical device incident reporting clock begin?
The reporting clock generally begins when the responsible organization becomes aware of information indicating a potentially reportable event.
It does not necessarily begin after the investigation is complete.
This is a critical distinction because many manufacturers receive information gradually.
A typical sequence may look like:
Why awareness-date management matters
A complaint may first arrive through:
- A distributor.
- A sales representative.
- Customer service.
- A field-service engineer.
- A local market representative.
If these channels do not have clear escalation requirements, valuable reporting time may be lost before Regulatory Affairs or Quality becomes involved.
A robust complaint-handling procedure should define:
⦿ What constitutes awareness.
⦿ Who can receive potentially reportable information.
⦿ When escalation is required.
⦿ Who records the awareness date.
⦿ Who owns the regulatory submission.
Health Canada defines awareness as the date at which the reporter becomes aware of the incident. FDA’s reporting deadlines are defined by the date on which the manufacturer becomes aware of information indicating the reportable event.
How quickly must a medical-device incident be reported?
The short answer is: it depends on the market, event category and responsible reporter.
A serious event generally requires faster action than a lower-risk event, but the reporting obligation is not determined only by severity. Manufacturers must also consider:
⦿ Whether the event meets the applicable reporting criteria.
⦿ When the organization became aware of the event.
⦿ Whether the requirement uses calendar days or working days.
⦿ Whether the reporter is the manufacturer, importer, sponsor or another regulated entity.
The table below provides a high-level comparison of initial reporting timelines.
Important: The table below serves merely as a practical guideline. Reporting needs to be determined in relation to the relevant regulatory requirements, and the authoritative guidance needs to be consulted prior to reporting.
What are the FDA MDR reporting timelines?
The FDA Medical Device Reporting (MDR) framework is one of the most commonly referenced incident-reporting systems globally. However, FDA timelines depend on both the event type and the reporting entity.
A manufacturer, importer and device-user facility do not have identical obligations.
FDA manufacturer 30-day reports
Manufacturers generally submit MDR reports within 30 calendar days after becoming aware of information that reasonably suggests a device may have:
⦿ Caused or contributed to a death.
⦿ Caused or contributed to a serious injury.
⦿ Malfunctioned in a way that would likely cause or contribute to death or serious injury if the malfunction were to recur.
The reporting assessment should begin when sufficient information exists to evaluate the event. Manufacturers should not assume that they must complete the entire investigation before determining whether reporting obligations exist.
FDA manufacturer five-day reports
FDA five-day reporting requirement applies under certain conditions only. This requirement cannot be taken as an expedited time limit applicable to all serious events associated with medical devices.
A manufacturer may need to submit a five-day report when:
⦿ FDA has specifically designated an event for five-day reporting; or
⦿ The manufacturer takes remedial action to prevent an unreasonable risk of substantial harm to public health.
The key distinction is that a serious event and a five-day report are not automatically the same thing.
Manufacturers should evaluate:
⦿ Whether FDA has identified the event category for five-day reporting.
⦿ Whether corrective action has been initiated to prevent significant public-health risk.
⦿ Whether the applicable reporting criteria have been met.
FDA importer reporting timelines
Importers have separate MDR responsibilities.
Generally, importers must report:
⦿ Event Category: Device-related death or serious injury
⦾Recipient: FDA and manufacturer
⦾Initial Timeline: 30 calendar days after awareness
⦿ Event Category: Qualifying device malfunction
⦾Recipient: Manufacturer
⦾Initial Timeline: 30 calendar days after awareness
The practical challenge for manufacturers is ensuring that importer communications do not create delays in internal assessment.
A complaint received by an importer may represent the beginning of the reporting timeline even if the legal manufacturer has not yet received complete information.
FDA device-user-facility reporting timelines
Device-user facilities have separate reporting obligations for certain device-related events.
⦿ Event Category: Device-related death
⦾ Recipient: FDA and manufacturer
⦾ Initial Timeline: 10 work days after awareness
⦿ Event Category: Device-related serious injury
⦾ Recipient: Manufacturer, or FDA if the manufacturer is unknown
⦾ Initial Timeline: 10 work days after awareness
These requirements highlight why manufacturers need effective communication channels with healthcare facilities, distributors and other external stakeholders.
What are the EU MDR vigilance timelines?
Under EU MDR, manufacturers must report serious incidents according to the applicable incident category.
Unlike FDA MDR, EU MDR uses the concept of serious incidents rather than the U.S. MDR terminology of reportable events.
The manufacturer must notify the relevant competent authority when the reporting criteria are met.
Serious public-health threat
Initial reporting timeline: No later than 2 days after awareness
This category applies to events presenting a serious risk requiring urgent action to protect patients, users or public health.
Death or unanticipated serious deterioration in health
Initial reporting timeline: No later than 10 days after awareness
Examples may include:
⦿ Unexpected death related to the use of the device.
⦿ Severe health deterioration.
⦿ Incidents where urgent action is needed to avoid serious injury.
Other serious incidents
Initial reporting timeline: No later than 15 days after awareness
15 days is not an authorization to delay action.
Manufacturers should report as soon as they establish or reasonably suspect the relationship between the incident and the device.
EU MDR operational considerations
A manufacturer should ensure that:
⦿ The incident is assessed promptly.
⦿ The manufacturer’s Authorized Representative is involved where applicable.
⦿ Relevant competent authorities are identified.
⦿ Initial reporting is not delayed while waiting for a complete investigation.
⦿ Follow-up information is provided as the investigation progresses.
To ensure the incident is assessed and investigated appropriately, manufacturers should also understand what constitutes an adequate medical device complaint investigation
What are the UK MHRA medical device incident reporting timelines?
Following Brexit, Great Britain operates a separate medical-device vigilance framework from EU MDR.
Incidents with medical devices marketed in Great Britain should be assessed according to UK regulations and reported to MHRA.
The UK approach is similar in principle to other vigilance systems: manufacturers should not wait for a complete investigation before considering whether a reportable incident may exist.
Serious public-health threat
Initial reporting timeline: Report without undue delay after awareness
Events presenting an urgent risk to public health require immediate escalation and assessment.
Death, serious injury or serious deterioration in health
Initial reporting timeline: Report without undue delay after awareness where vigilance reporting criteria are met
Manufacturers should assess:
⦿ Whether the device caused or contributed to the outcome.
⦿ Whether the event represents an unacceptable risk.
⦿ Whether similar incidents could occur again.
⦿ Whether corrective action is required.
UK reporting responsibilities
Depending on the device and regulatory status, responsibility may involve:
- Manufacturer.
- UK Responsible Person (where applicable).
- Other parties involved in placing the device on the Great Britain market.
A distributor or healthcare professional may be the first party to identify the issue, but the manufacturer or responsible regulatory entity must ensure appropriate assessment and reporting.
UK and EU reporting should not be combined automatically
The most frequent mistake made in a global system of reporting is the assumption that the reporting of an EU MDR serious incident report will also satisfy UK obligations.
While the underlying incident may be the same, the manufacturer should consider:
⦿ Whether the medical device is available in both markets.
⦿ Which regulatory framework applies.
⦿ Which authority must be notified.
⦿ Whether separate submissions or communications are required.
What are the Health Canada reporting timelines?
Health Canada applies mandatory incident reporting requirements for manufacturers and importers under the Canadian Medical Devices Regulations.
Death or serious deterioration in health
Initial reporting timeline: Within 10 calendar days after awareness
Examples may include:
⦿ Life-threatening illness or injury.
⦿ Permanent impairment.
⦿ Permanent damage to a body structure.
⦿ Medical or surgical intervention required to prevent permanent harm.
Potential recurrence causing death or serious deterioration
Initial reporting timeline: Within 30 calendar days after awareness
This is an especially significant reporting incident since the device would not have caused serious damage during the first occurrence.
For example:
The device malfunctions while in use; however, the problem is caught by the health care staff before any harm comes to the patient.
Preliminary and follow-up reporting
Health Canada reporting does not require manufacturers to complete the entire investigation before initial notification.
The manufacturer may need to provide:
⦿ Initial incident information.
⦿ Investigation status.
⦿ Proposed corrective actions.
⦿ Follow-up information.
⦿ Final conclusions.
This reinforces an important principle across global markets:
Initial reporting and investigation are connected processes, not sequential activities.
What are the TGA adverse-event reporting timelines?
In Australia, sponsors have responsibility for assessing and reporting applicable medical-device adverse events to the Therapeutic Goods Administration (TGA).
Serious threat to public health
Initial reporting timeline: Within 48 hours after awareness.
Death or serious deterioration in health
Initial reporting timeline: Within 10 days after awareness.
Event or recurrence that may lead to death or serious deterioration
Initial reporting timeline: Within 30 days after awareness.
TGA follow-up and final reporting
Incident reporting may continue after the initial submission.
Manufacturers and sponsors should maintain oversight of:
⦿ Investigation progress.
⦿ Device evaluation.
⦿ Similar complaints.
⦿ Corrective actions.
⦿ Final conclusions.
TGA requires continued notification of the progress when investigations remain open.
Incident reporting example: Why awareness date and market matter
Consider a battery-operated blood-pressure monitor used by a healthcare professional during an urgent treatment decision.
The device loses power during use.
The complaint is initially received by a distributor. The manufacturer receives complete information several days later.
The company must assess:
When did awareness occur?
Was awareness established when:
⦿ The distributor received the complaint?
⦿ The manufacturer received the complaint?
⦿ Sufficient information became available to identify a potentially reportable event?
Which reporting criteria apply?
The company must evaluate:
⦿ Did it cause patient harm?
⦿ Is recurrence likely to cause significant harm?
⦿ Was this a case of malfunction that qualifies for reporting?
⦿ Is this device available in other countries?
⦿ What timeline is relevant?
Which timeline applies?
The answer may differ depending on:
⦿ FDA MDR requirements.
⦿ EU MDR vigilance requirements.
⦿ UK/MHRA requirements.
⦿ Health Canada requirements.
⦿ TGA requirements.
The failure mechanism may be identical, but reporting responsibilities and deadlines may not be.
Key lesson: A global company requires one consistent incident record, but market-specific deadlines have to be determined separately.
Common causes of missed medical device reporting deadlines
A missed reporting deadline can create additional regulatory scrutiny, which is why manufacturers should understand the causes of missed medical device reporting deadlines and strengthen escalation controls.
Waiting for the investigation to finish
A complete root-cause analysis is not always required before an initial report. However, manufacturers must still maintain a documented and defensible investigation process. Understanding complaint investigation adequacy is essential when preparing follow-up information and supporting regulatory decisions.
Failing to record the awareness date
Without a documented awareness date, the reporting timeline may become difficult to defend.
Allowing distributors or service teams to retain complaint information
External communication channels must have clear escalation requirements.
Using one timeline for every market
FDA, EU MDR, UK/MHRA, Health Canada, and TGA timelines differ.
Confusing calendar days and working days
A five-work-day requirement cannot be treated the same as a 10-calendar-day requirement.
Assessing only the country where the incident occurred
The same device, component or failure mechanism may exist globally.
Failing to assign ownership
Every reporting obligation should have a responsible owner.
Treating software reminders as a substitute for governance
The systems support compliance, but the decision-making process is still done by professionals.
Need support managing global medical device incident reporting requirements?
FAQs
How quickly must a medical-device incident be reported?
The timeline depends on the regulatory authority, event category and responsible reporter. Initial reporting periods may range from 48 hours to 30 days depending on the market.
When does the incident-reporting clock begin?
The incident-reporting clock typically starts ticking once the responsible organization is made aware of information indicating that there may have been an incident, rather than after completion of the investigation.
Are reporting periods measured in calendar days or working days?
Both may apply. FDA, for example, uses both calendar-day and work-day requirements depending on the reporter and event category.
Can the investigation continue after the initial report?
Yes. Initial reporting and investigation often occur in parallel. Additional information may be submitted after further investigation.
Can one incident have different deadlines in different markets?
Yes. The same incident may require different assessments and reporting timelines depending on the applicable regulatory framework.
What are the MHRA medical device incident reporting timelines?
Medical Device UK/MHRA reporting times vary based on the type of incident and the associated vigilance responsibilities.
